ARMP Posts $1.1M Grant Rev, $6.1M R&D Spend, $3.4M G&A, $5.4M Impairment, $124.3M Net Loss, $14.1M Cash, Amends $50M Credit, 36.6M Shares Outstanding
Armata Pharmaceuticals, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $7.80
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS